Masseter Botulinum Toxin vs. Buccal Fat Removal: Two Very Different Roads to a Slimmer Lower Face

Patients often arrive at consultations asking for a slimmer lower face and assuming there is one procedure that delivers it. In reality, lower facial width comes from at least three separate tissue layers: bone, muscle, and fat. The two most requested interventions, masseter botulinum toxin injections and buccal fat pad removal, each target only one of those layers. Choosing the wrong one means paying for a result that anatomy cannot deliver.

What each procedure actually does

The masseter is the thick chewing muscle that runs from the cheekbone down to the angle of the jaw. In some people, particularly those who clench or grind their teeth, this muscle hypertrophies the way any muscle does with heavy use, and the jaw angle widens visibly. Botulinum toxin blocks the release of acetylcholine at the neuromuscular junction, which reduces the muscle's contraction strength. Over roughly six to twelve weeks of reduced workload, the muscle atrophies and the width of the jaw angle decreases. The effect is temporary. Most patients see the muscle regain bulk over four to six months as nerve terminals recover, which is why maintenance treatments are standard.

Buccal fat removal is a surgical excision of a portion of the buccal fat pad, a discrete, encapsulated fat compartment that sits deep in the mid to lower cheek, between the masseter and the buccinator muscle. It is not the same as subcutaneous cheek fat, and it does not shrink meaningfully with weight loss in most adults. Removing part of it through a small incision inside the mouth reduces fullness below the cheekbone, creating a more sculpted or hollowed contour. The change is permanent, because the fat pad does not regenerate.

The diagnostic question: muscle or fat?

A simple clinical test separates the two. Clench your teeth hard while palpating the area just in front of the jaw angle. If a firm mass bulges under your fingers and the face looks noticeably wider during the clench, masseter hypertrophy is contributing to the width. If the fullness is soft, sits higher in the cheek, and does not change with clenching, the buccal fat pad or subcutaneous fat is the more likely culprit. Many faces have both, and some have neither: a wide mandibular bone produces lower facial width that neither procedure can address, and only skeletal surgery changes bone.

Reversibility and the aging question

This is where the two options diverge most sharply. Masseter toxin wears off. If a patient dislikes the result, or if their face changes with age, the treatment simply stops. Buccal fat removal cannot be undone without fat grafting, which is a more complex and less predictable repair.

That matters because the midface loses volume with age. Deep fat compartments deflate through the forties and fifties, and cheeks that looked pleasantly full at 28 can look gaunt at 48. Surgeons who counsel conservatively point out that a buccal fat pad removed at 25 is volume the patient can never get back when aging begins subtracting on its own. This is why many practitioners now reserve the procedure for patients with genuinely prominent buccal compartments rather than anyone seeking a trend-driven hollow cheek look, and why partial rather than total pad removal has become the more common technique.

Risk profiles

Masseter injections carry mostly transient risks: temporary chewing fatigue, asymmetric smile if the toxin diffuses into the risorius or zygomaticus muscles, and in rare cases a paradoxical bulging of untreated muscle fibers. Dosing that is too aggressive can also soften the jawline in patients who relied on masseter bulk for definition. Skilled injectors map the muscle borders and keep injections deep and low to avoid the smile muscles.

Buccal fat removal is surgery, and its risks are surgical: injury to the buccal branch of the facial nerve, injury to the parotid duct which passes near the fat pad, hematoma, infection, and asymmetry from unequal removal. These complications are uncommon in experienced hands but they are not reversible the way a bad toxin result is.

Myth check: neither procedure spot-reduces general facial fat

A persistent misconception is that either treatment slims a round face caused by overall subcutaneous fat or weight. Masseter toxin only shrinks muscle. Buccal fat removal only removes one deep compartment, and patients with generalized facial fullness often see little visible change because the surrounding subcutaneous layer masks the excision. For those patients, weight management, or in select cases injectable fat-dissolving agents or energy-based devices targeting the subcutaneous layer, are the relevant conversation.

The bottom line

Think of it as a matching exercise. Bulky, clench-responsive muscle at the jaw angle points toward botulinum toxin, a reversible and repeatable option. A soft, discrete pocket of deep cheek fullness in a patient with otherwise low facial fat points toward buccal fat evaluation, with the understanding that removal is permanent and aging is not kind to over-hollowed cheeks. A wide jaw from bone is a different problem entirely. A careful physical exam, not a trend, should decide which layer gets treated.